Alto Neuroscience, Inc. (ANRO)

Listed in the US · Manufacturing · Pharmaceutical preparations

$23.47

As of 29 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close $23.47 on 29 Oct 2026. The share price traded between $10.20 and $37.48 (intraday) over the last 12 months.

The closes as a table

Date	Close

Key figures

1-year range (intraday)

Low $10.20High $37.48

Market cap$921Mlast close × shares

Return on equity−41.8%year to Dec 2025

Debt to equity0.11year to Dec 2025

Dividend yieldnonelast 12 months

Price trend

Stage 3 (topping): the 150-day average has stopped rising, or the price is below a rising one, for 22 trading days.
Supertrend (10, 3): the price has closed below the line for 33 trading days.

Revenue and profit

RevenueNet profit$ million

-80-60-40-200

Dec 2023Net profit -36.30Dec ’23

Dec 2024Net profit -61.43Dec ’24

Dec 2025Net profit -63.24Dec ’25

Year	Dec 2023	Dec 2024	Dec 2025
Net profit	-36.30	-61.43	-63.24
Borrowings	9.86	10.25	16.76

$ million.

Recent filings

Questions about Alto Neuroscience, Inc.

What is Alto Neuroscience, Inc.'s market value?

Alto Neuroscience, Inc.'s market value is $921M as of 29 Oct 2026 close: the last close times the shares in issue.

Go further with ANRO

Free to start: test a trading idea on ANRO's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Test a strategy on ANRO Open the full deep dive

Same industry

The largest companies in the same industry (Pharmaceutical preparations), by market value.

Eli Lilly & Co (LLY)Johnson & Johnson (JNJ)AbbVie Inc. (ABBV)Merck & Co., Inc. (MRK)Novartis AG (NVS)Astrazeneca PLC (AZN)Abbott Laboratories (ABT)Novo Nordisk A S (NVO)Pfizer Inc (PFE)Vertex Pharmaceuticals Inc (VRTX)Bristol Myers Squibb Co (BMY)Sanofi (SNY)

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

Last close: the closing price on the date shown. The page follows the market's close; it doesn't show prices during the session. A price older than the market's latest close, or a last trade that isn't a close, is labelled as the last price, with the session it is from.
1-year range: the lowest and highest prices traded during the sessions of the last year (intraday), so they can lie outside the closing prices.
Market cap: the last close times the shares in issue. It is n/a when it doesn't agree with the company's own reported figures (for example a depositary share counted as an ordinary share).
P/E: the last close divided by earnings per share over the last four reported quarters, the profit that belongs to the company's shareholders per share, as the company reports it. So P/E can differ from market cap divided by the net profit shown (a different share count, or the profit before minority interests; where they differ by more than 10%, a note under the figures gives both). A company that reports only once a year has its latest year's earnings, and the P/E names that year; when that year ended more than about 15 months before the close, P/E is n/a. A loss has no P/E. Above 1,000 it is n/a.
EBITDA margin: operating profit before depreciation, interest and tax (and before other income), as a share of revenue in the latest reported year, the table's last column.
Net margin: net profit as a share of revenue in the latest reported period. Return on equity, the margins and debt to equity each use inputs from that one year; if one input is missing for it, the figure is n/a. When that year ended more than about 15 months before the close, they are n/a too.
Dividend yield: every dividend per share with an ex-date in the 12 months to the last close, special dividends included, as a share of that close. n/a when the company's dividends couldn't be read.
n/m: not meaningful. A margin or return beyond ±1,000% comes from revenue or equity near zero, so it is not shown as a number.